PE-backed Pinnacle adds Nelson to board


Pinnacle Treatment Centers, a provider of inpatient and outpatient treatment for those suffering from substance use disorders, has named Jeff Nelson to its board of directors. Nelson is the former CEO of Healogics. Pinnacle Treatment Centers is backed by Linden Capital Partners.

PRESS RELEASE

Mt. Laurel, NJ (March 14, 2019) – Pinnacle Treatment Centers (“Pinnacle”), a leading provider of inpatient and outpatient treatment for those suffering from substance use disorders, announced today the appointment of Jeff Nelson to its Board of Directors. Having most recently served as CEO of Healogics, Mr. Nelson brings over 30 years of healthcare experience to the board, including over 15 years in executive leadership positions.

“We are very excited to welcome Jeff to our board and are thrilled about his immediate impact on our company and its focus on patient care,” said Joe Pritchard, Chief Executive Officer of Pinnacle. “Jeff oversaw significant growth at Healogics, and I am confident we will benefit from his guidance as Pinnacle continues to grow at a fast pace.”

Mr. Nelson served as the CEO of Healogics, the nation’s largest provider of advanced wound care services, and its predecessor for over a decade and previously served as president of Thoratec, a developer and manufacturer of implantable cardiac assist devices, which is now part of Abbott. Prior to Thoratec, Mr. Nelson held leadership positions within Philips Medical Systems, ADAC Laboratories, Syncor International and Baxter. Mr. Nelson earned a Bachelor of Science in Applied Math-Economics from Brown University and a Master of Business Administration from the Kellogg School of Management at Northwestern University.

“My commitment to maintaining high quality patient outcomes through evidence-based care aligns well with Pinnacle’s strategic priorities, and I am excited to work with management and the rest of the board as Pinnacle helps address the substance abuse epidemic,” said Mr. Nelson.

Mr. Nelson joins the Board of Directors of Pinnacle alongside healthcare executives, Gary Kagan, Pinnacle Director and Linden Operating Partner, and Andy Sekel, former CEO of OptumHealth Behavioral Solutions.

About Pinnacle Treatment Centers
Pinnacle Treatment Centers is a leading comprehensive provider of substance abuse treatment services to individuals that are addicted to drugs and / or alcohol. Founded in 2006, the Company has grown into an organization that operates over 60 substance abuse treatment facilities across 6 states. Pinnacle treats over 13,000 people daily and provides a full continuum of care, including detoxification, residential, outpatient, and transitional living programs. Pinnacle is CARF accredited and all locations include physicians, nurses, clinicians, administrative, and support staff.

For more information please visit www.PinnacleTreatment.com.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on investing in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms across the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.